SU
Surgical Science Sweden AB
SUSRF · OTC
$5.20 +0.00% (+$0.00)
Market Cap 2.61B kr
P/E Ratio 28.06x
Div. Yield -
ROE 2.12%
Bulios Fair Price
$3.48
33.1% downside
Trenutna cena
$5.2
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SUSRF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
64 /100
Fair P/E 28.06x
P/B 0.58x
EV/EBITDA 9.21x
Growth
22 /100
Declining EPS growth 29.55%
Book val. growth 0.20%
Rev. growth 7.24%
Profitability
69 /100
Strong Gross margin 62.24%
FCF margin 10.38%
Net margin 9.11%
Quality
11 /100
Poor ROIC 2.24%
Asset turnover 0.21x
ROE 2.12%
Debt
100 /100
Low Debt/Equity 0.00x
Net debt/EBITDA -3.06x
Current ratio 4.24x
Stability
84 /100
Stable Beta 0.61x
Profitable years 6
Rev. volatility 6.34%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SUSRF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Tom Englund
Employees
313
Headquarters
Gothenburg
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report